Cargando…
Long-Term Gene Therapy with Thrombospondin 2 Inhibits TGF-β Activation, Inflammation and Angiogenesis in Chronic Allograft Nephropathy
We recently identified Thrombospondin-2 (TSP-2) as a regulator of matrix remodelling and inflammation in experimental kidney disease by using TSP-2 null mice and successfully proved TSP-2 overexpression as a therapeutic concept in a short term glomerulonephritis model in the rat. In this current stu...
Autores principales: | Daniel, Christoph, Vogelbacher, Regina, Stief, Andrea, Grigo, Christina, Hugo, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871554/ https://www.ncbi.nlm.nih.gov/pubmed/24376766 http://dx.doi.org/10.1371/journal.pone.0083846 |
Ejemplares similares
-
Thrombospondin-4 mediates TGF-β-induced angiogenesis
por: Muppala, Santoshi, et al.
Publicado: (2017) -
Correlation of enhanced thrombospondin-1 expression, TGF-β signalling and proteinuria in human type-2 diabetic nephropathy
por: Hohenstein, Bernd, et al.
Publicado: (2008) -
Thrombospondins function as regulators of angiogenesis
por: Bornstein, Paul
Publicado: (2009) -
TGF-β promotes microtube formation in glioblastoma through thrombospondin 1
por: Joseph, Justin V, et al.
Publicado: (2021) -
Matrix-bound thrombospondin promotes angiogenesis in vitro
Publicado: (1994)